Rocket Pharma upgraded at Goldman Sachs on Danon disease therapy
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Rocket Pharma updates progress on RP-A501 for Danon disease seekingalpha.com